
|Videos|December 11, 2020
Management of high-risk NMIBC: Options for treatment expand
Author(s)Urology Times staff
“As urologists, we all need to start speaking in risk stratification criteria,” says Katie Murray, DO.
Advertisement
In this video, Katie Murray, DO, shares her takeaways from a discussion at the 2020 Society of Urologic Oncology annual meeting titled, Optimizing Management of High Risk NMIBC – Case-Based Discussion, for which she served as a panelist. Murray is an assistant professor of surgery-urology at the University of Missouri, Columbia.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Real-World Evidence in mCSPC Management
4
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
5



















